A timeline chart showing the development stages of two experimental drugs, RNA-LNPs and BPH-555, for treating autoimmune diseases, including their preclinical and phase 1 trial timelines from 2026 to 2028.

© 2026 Axelyf, Inc..

Partnering and collaboration

Axelyf is exploring partnership and collaboration on AXL lipid library and capabilities to deliver best-in-class RNA-LNP technology for medicines. Please get in touch with us at info@axelyfbio.org if you’d like to learn more about our technology.